{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:57:25Z","timestamp":1793854645229,"version":"4.6.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011386","name":"Huazhong Agriculture University National Key Laboratory of Agricultural Microbiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1800800"],"award-info":[{"award-number":["2022YFD1800800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.virol.2024.110162","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T14:11:10Z","timestamp":1719497470000},"page":"110162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide"],"prefix":"10.1016","volume":"597","author":[{"given":"Hechao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5424-5474","authenticated-orcid":false,"given":"Ping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2024.110162_bib1","first-page":"1","article-title":"Production of Brucella lumazine synthase recombinant protein to design a subunit vaccine against undulant fever","volume":"74","author":"Akbari","year":"2019","journal-title":"Arch Razi Inst"},{"key":"10.1016\/j.virol.2024.110162_bib2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.vaccine.2012.11.072","article-title":"Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice","volume":"31","author":"Alvarez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110162_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/09680519040100020401","article-title":"A new method for removing endotoxin from plasma using hemocompatible affinity chromatography technology, applicable for extracorporeal treatment of septic patients","volume":"10","author":"Amoureux","year":"2004","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.virol.2024.110162_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-8682-8_4","article-title":"Phage on tap: a quick and efficient protocol for the preparation of bacteriophage laboratory stocks","volume":"1838","author":"Bonilla","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2024.110162_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fimmu.2019.00440","article-title":"Extra-neutralizing FcR-mediated antibody functions for a universal influenza vaccine","volume":"10","author":"Boudreau","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2024.110162_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217607","article-title":"Continuous evolution of influenza A viruses of swine from 2013 to 2015 in Guangdong, China","volume":"14","author":"Cao","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110162_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41423-023-01122-w","article-title":"SARS-CoV-2 immunity in animal models","volume":"21","author":"Chen","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.virol.2024.110162_bib8","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1038\/s41598-017-07372-9","article-title":"The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin","volume":"7","author":"Deloizy","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2024.110162_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12250-020-00283-6","article-title":"Flu universal vaccines: new tricks on an old virus","volume":"36","author":"Du","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virol.2024.110162_bib10","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s00253-021-11225-x","article-title":"Functional evaluation of a recombinant fungal immunomodulatory protein from L. rhinocerus produced in P. pastoris and E. coli host expression systems","volume":"105","author":"Ejike","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.virol.2024.110162_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/bit.20069","article-title":"Highly selective membranes in protein ultrafiltration","volume":"86","author":"Feins","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.virol.2024.110162_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009897","article-title":"Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection","volume":"17","author":"Geng","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2024.110162_bib13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/21645515.2019.1565269","article-title":"The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity","volume":"15","author":"Gianchecchi","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2024.110162_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/laban0911-263a","article-title":"Steps toward a universal flu vaccine","volume":"40","author":"Harrington","year":"2011","journal-title":"Lab. Anim"},{"key":"10.1016\/j.virol.2024.110162_bib15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.aba2754","article-title":"Toward a universal flu vaccine","volume":"367","author":"Herold","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110162_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2017.11.018","article-title":"A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model","volume":"515","author":"Herrera-Rodriguez","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110162_bib17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110162_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2024.110162_bib19","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1021\/acs.nanolett.0c04687","article-title":"Immunization with a self-assembled nanoparticle vaccine elicits potent neutralizing antibody responses against EBV infection","volume":"21","author":"Kang","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.virol.2024.110162_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.virol.2024.110162_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010755","article-title":"Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle","volume":"18","author":"Kim","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2024.110162_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2013.06.010","article-title":"Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection","volume":"99","author":"Kim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110162_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00429-21","article-title":"Neutralizing antibodies induced by first-generation gp41-stabilized HIV-1 envelope trimers and nanoparticles","volume":"12","author":"Kumar","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.virol.2024.110162_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1216364","article-title":"SpyTag\/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion","volume":"13","author":"Lampinen","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virol.2024.110162_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virol.2019.07.027","article-title":"Fusion of pseudorabies virus glycoproteins to IgG Fc enhances protective immunity against pseudorabies virus","volume":"536","author":"Li","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110162_bib26","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1016\/j.vaccine.2020.05.013","article-title":"Efficient mucosal vaccination of a novel classical swine fever virus E2-Fc fusion protein mediated by neonatal Fc receptor","volume":"38","author":"Li","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110162_bib27","article-title":"Bacteriophage T4 vaccine platform for next-generation influenza vaccine development","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2024.110162_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/IJN.S387160","article-title":"A multivalent and thermostable nanobody neutralizing SARS-CoV-2 omicron (B.1.1.529)","volume":"18","author":"Lu","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.virol.2024.110162_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2020.10.007","article-title":"Immunization with a recombinant fusion of porcine reproductive and respiratory syndrome virus modified GP5 and ferritin elicits enhanced protective immunity in pigs","volume":"552","author":"Ma","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110162_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ame2.12111","article-title":"Guidelines for the ethical review of laboratory animal welfare people's Republic of China national standard GB\/T 35892-2018 [issued 6 february 2018 effective from 1 september 2018]","volume":"3","author":"MacArthur Clark","year":"2020","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.virol.2024.110162_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12026-018-8991-x","article-title":"Matrix-M adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice","volume":"66","author":"Magnusson","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.virol.2024.110162_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12929-019-0572-3","article-title":"M2e-based universal influenza vaccines: a historical overview and new approaches to development","volume":"26","author":"Mezhenskaya","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.virol.2024.110162_bib33","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1016\/j.vaccine.2021.08.010","article-title":"A Research and Development (R&D) roadmap for influenza vaccines: looking toward the future","volume":"39","author":"Moore","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110162_bib34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2024.110162_bib35","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/22221751.2020.1760735","article-title":"Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV","volume":"9","author":"Okba","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2024.110162_bib36","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.020421","article-title":"Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR Project","volume":"9","author":"Paget","year":"2019","journal-title":"J Glob Health"},{"key":"10.1016\/j.virol.2024.110162_bib37","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.D059725","article-title":"Quantitative lipopolysaccharide analysis using HPLC\/MS\/MS and its combination with the limulus amebocyte lysate assay","volume":"56","author":"Pais de Barros","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.virol.2024.110162_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13520","article-title":"Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months","volume":"7","author":"Pelliccia","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2024.110162_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1747-0285.2008.00746.x","article-title":"Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine","volume":"73","author":"Pimentel","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.virol.2024.110162_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virol.2019.08.008","article-title":"Mammalian pathogenicity and transmissibility of a reassortant Eurasian avian-like A(H1N1v) influenza virus associated with human infection in China (2015)","volume":"537","author":"Pulit-Penaloza","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110162_bib41","article-title":"Intranasal nanovaccine confers homo- and hetero-subtypic influenza protection","volume":"14","author":"Qi","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.virol.2024.110162_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7774\/cevr.2014.3.2.227","article-title":"Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine development","volume":"3","author":"Ra","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.virol.2024.110162_bib43","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.vaccine.2016.01.028","article-title":"Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB\/c mice","volume":"34","author":"Rappazzo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110162_bib44","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2015.04.066","volume":"33","author":"Ravin","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110162_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/v13122443","article-title":"Fc-Mediated E2-dimer subunit vaccines of atypical porcine pestivirus induce efficient humoral and cellular immune responses in piglets","volume":"13","author":"Ren","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2024.110162_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.32607\/20758251-2019-11-4-22-32","article-title":"Non-neutralizing antibodies directed at conservative influenza antigens","volume":"11","author":"Sedova","year":"2019","journal-title":"Acta Naturae"},{"key":"10.1016\/j.virol.2024.110162_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01603-17","article-title":"In vitro neutralization is not predictive of prophylactic efficacy of broadly neutralizing monoclonal antibodies CR6261 and CR9114 against lethal H2 influenza virus challenge in mice","volume":"91","author":"Sutton","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110162_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9070739","article-title":"M2e-Based influenza vaccines with nucleoprotein: a review","volume":"9","author":"Tan","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.virol.2024.110162_bib49","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/22221751.2019.1637284","article-title":"Characterization of swine-origin H1N1 canine influenza viruses","volume":"8","author":"Wang","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2024.110162_bib50","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/14760584.2018.1541408","article-title":"Universal influenza vaccines: from viruses to nanoparticles","volume":"17","author":"Wang","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2024.110162_bib51","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1016\/j.vaccine.2020.07.015","article-title":"A biomimetic VLP influenza vaccine with interior NP\/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy","volume":"38","author":"Wei","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110162_bib52","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038489","article-title":"The ecology and evolution of influenza viruses","volume":"10","author":"Wille","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.virol.2024.110162_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/nnm-2022-0298","article-title":"Nanoparticle vaccine based on the envelope protein domain III of Japanese encephalitis virus elicits robust protective immune responses in mice","volume":"18","author":"Yao","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.virol.2024.110162_bib54","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1128\/AEM.01547-07","article-title":"Extracellular expression of a functional recombinant Ganoderma lucidium immunomodulatory protein by Bacillus subtilis and Lactococcus lactis","volume":"74","author":"Yeh","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.virol.2024.110162_bib55","article-title":"A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci Rep."},{"key":"10.1016\/j.virol.2024.110162_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9010039","article-title":"Comparison of the pathogenicity of two different branches of senecavirus a strain in China","volume":"9","author":"Zhang","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2024.110162_bib57","article-title":"T cell activating thermostable self-assembly nanoscaffold tailored for cellular immunity antigen delivery","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.virol.2024.110162_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/vaccines9010045","article-title":"A self-assembling ferritin nanoplatform for designing classical swine fever vaccine: elicitation of potent neutralizing antibody","volume":"9","author":"Zhao","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110162_bib58","doi-asserted-by":"crossref","first-page":"21872","DOI":"10.1021\/acsami.2c01028","article-title":"Flagellin\/Virus-like particle hybrid platform with high immunogenicity, safety, and versatility for vaccine development","volume":"14","author":"Zhao","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.virol.2024.110162_bib60","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2","volume":"79","author":"Zharikova","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110162_bib61","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.virs.2022.01.001","article-title":"Combined insertion of basic and non-basic amino acids at hemagglutinin cleavage site of highly pathogenic H7N9 virus promotes replication and pathogenicity in chickens and mice","volume":"37","author":"Zhou","year":"2022","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virol.2024.110162_bib62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12985-022-01936-6","article-title":"Genetic characterization and pathogenicity of a Eurasian avian-like H1N1 swine influenza reassortant virus","volume":"19","author":"Zhu","year":"2022","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2024.110162_bib63","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/j.vaccine.2022.09.058","article-title":"Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA","volume":"40","author":"Zhu","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110162_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120672","article-title":"Self-assembled peptide nanorod vaccine confers protection against influenza A virus","volume":"269","author":"Zottig","year":"2021","journal-title":"Biomaterials"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224001831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224001831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:56:46Z","timestamp":1762221406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224001831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":64,"alternative-id":["S0042682224001831"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110162","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110162"}}